Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
29 March 2018
Answer given by President Juncker on behalf of the Commission
Question reference: E-000695/2018

1. Paragraph 15 of the Guidelines for Brexit negotiations of the European Council (Article 50) of 29 April 2017 states that ‘the future location of the seats of EU agencies and facilities located in the United Kingdom is a matter for the 27 Member States to settle rapidly’(1).

In the margins of the European Council (Article 50) of 22 June 2017, the Heads of State or Government of 27 Member States endorsed the Procedure leading up to a decision on the relocation of the European Medicines Agency and the European Banking Authority, including six criteria which interested Member States should address in their offer to host one or both of the Agencies(2).

The Commission was invited to examine the offers submitted by the Member States and to present its assessment to the Secretary-General of the Council.

For this purpose, the Commission was provided by the Secretary-General of the Council with both the public and the confidential versions of Member States’ offers. The offer from the Netherlands for the European Medicines Agency can be found on the website of the European Council, including the part of the offer which initially the Netherlands had wished to keep confidential but in the meantime decided to make publicly available(3).

2. On 20 November 2017, the 27 Member States selected the agencies' new seats. It is now for the European Medicines Agency in cooperation with the authorities of the Netherlands to ensure business continuity, as per the criteria of the endorsed procedure.

As regards information on the preparedness of the Amsterdam site, it is the authorities of the Netherlands that can provide the Honourable Members with full and updated information.


Last updated: 23 April 2018Legal notice